These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3170393)

  • 1. A study of amikacin given once versus twice daily in serious infections.
    Maller R; Isaksson B; Nilsson L; Sörén L
    J Antimicrob Chemother; 1988 Jul; 22(1):75-9. PubMed ID: 3170393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
    Karachalios GN; Houpas P; Tziviskou E; Papalimneou V; Georgiou A; Karachaliou I; Halkiadaki D
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):561-4. PubMed ID: 9799062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group.
    Maller R; Ahrne H; Eilard T; Eriksson I; Lausen I
    J Antimicrob Chemother; 1991 May; 27 Suppl C():121-8. PubMed ID: 1856141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
    Giamarellou H; Yiallouros K; Petrikkos G; Moschovakis E; Vavouraki E; Voutsinas D; Sfikakis P
    J Antimicrob Chemother; 1991 May; 27 Suppl C():73-9. PubMed ID: 1906864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
    Beaucaire G; Leroy O; Beuscart C; Karp P; Chidiac C; Caillaux M
    J Antimicrob Chemother; 1991 May; 27 Suppl C():91-103. PubMed ID: 1856149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe gram-negative infections.
    Kafetzis DA; Sianidou L; Vlachos E; Davros J; Baïramis T; Papandreou Y; Paraskaki E; Scouroliakou M; Hadzis A; Papadatos J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():105-12. PubMed ID: 1906861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group.
    Maller R; Ahrne H; Holmen C; Lausen I; Nilsson LE; Smedjegård J
    J Antimicrob Chemother; 1993 Jun; 31(6):939-48. PubMed ID: 8360131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single daily dose amikacin in paediatric patients with severe gram-negative infections.
    Trujillo H; Robledo J; Robledo C; Espinal D; Garces G; Mejia J; Restrepo C; Restrepo F; Mejia de Rodriguez GI; Tamayo de Guitierrez MC
    J Antimicrob Chemother; 1991 May; 27 Suppl C():141-7. PubMed ID: 1856143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin once daily: a new dosing regimen based on drug pharmacokinetics.
    Maller R; Emanuelsson BM; Isaksson B; Nilsson L
    Scand J Infect Dis; 1990; 22(5):575-9. PubMed ID: 2259867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
    Marik PE; Havlik I; Monteagudo FS; Lipman J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin once daily plus metronidazole versus amikacin twice daily plus metronidazole in colorectal surgery.
    Mendes da Costa P; Kaufman L
    Hepatogastroenterology; 1992 Aug; 39(4):350-4. PubMed ID: 1427582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.
    Holm SE; Hill B; Löwestad A; Maller R; Vikerfors T
    J Antimicrob Chemother; 1983 Oct; 12(4):393-402. PubMed ID: 6643334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations.
    Vaidyanathan S; Peloquin C; Wyndaele JJ; Buczynski AZ; Almog Y; Markantonis SL; Jayawardena V; Soni BM; Cannon J; Vidal J
    ScientificWorldJournal; 2006 Feb; 6():187-99. PubMed ID: 16493523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the administration of amikacin by intramuscular and intravenous routes in neonatal resuscitation].
    Deramoudt-Dutrus V; Betremieux P; Lefrançois C; Malledant Y; Avril JL; Le Marec B
    Pediatrie; 1989; 44(2):125-32. PubMed ID: 2654876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study of the efficacy and safety of multiple daily doses of amikacin versus one daily dose for children with perforated appendicitis in Costa Rica.
    Pérez V; Saénz D; Madriz J; Harhay M; Feoli J; Castro M; Odio C
    Int J Infect Dis; 2011 Aug; 15(8):e569-75. PubMed ID: 21733727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates.
    Vučićević K; Rakonjac Z; Miljković B; Janković B; Prostran M
    J Pharmacol Sci; 2014; 124(2):138-43. PubMed ID: 24441865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.